Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.

Boomsma MM, Stegeman CA, Oost-Kort WW, Kallenberg CG, Moguilevsky N, Limburg PC, Tervaert JW.

J Immunol Methods. 2001 Aug 1;254(1-2):47-58.

PMID:
11406152
2.

Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood.

Kas-Deelen AM, Harmsen MC, De Maar EF, Oost-Kort WW, Tervaert JW, Van Der Meer J, Van Son WJ, The TH.

Kidney Int. 2000 Dec;58(6):2533-42.

3.

In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.

Franssen CF, Huitema MG, Muller Kobold AC, Oost-Kort WW, Limburg PC, Tiebosch A, Stegeman CA, Kallenberg CG, Tervaert JW.

J Am Soc Nephrol. 1999 Jul;10(7):1506-15.

4.

Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis.

Franssen CF, Stegeman CA, Oost-Kort WW, Kallenberg CG, Limburg PC, Tiebosch A, De Jong PE, Tervaert JW.

J Am Soc Nephrol. 1998 Oct;9(10):1915-23.

Supplemental Content

Loading ...
Support Center